Read Full Article
Bloomberg | Apr 19, 2018 Procter & Gamble Co. agreed to buy Merck KGaA’s consumer-health business for 3.4 billion euros (US$4.2 billion) to bolster growth, betting that vitamins and decongestants can hasten its comeback...
We have found an ideal partner for consumer health and we have achieved a very attractive valuation.
We like the steady, broad-based growth of the OTC Health Care market and are pleased to add the consumer-health portfolio.
Each company will take back its own brand and product assets to re-establish independent OTC businesses.